Bill Sponsors: NJ A2240 | 2022-2023 | Regular Session

Bill Title: Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

Spectrum: Partisan Bill (Democrat 2-0)

Status: (Introduced - Dead) 2022-02-07 - Introduced, Referred to Assembly Health Committee [A2240 Detail]

Text: Latest bill text (Introduced) [HTML]

Sponsors

NameTypeSponsorshipDistrictFinancialEncyclopediaBiography
Representative Carol Murphy [D]PrimarySponsored BillsHD-007FollowTheMoneyBallotpediaVoteSmart
Representative Clinton Calabrese [D]PrimarySponsored BillsHD-036FollowTheMoneyBallotpediaVoteSmart

Social Comments on NJ A2240

feedback